CPMG Inc

Q2 2019 13F Combination Report, Options Holdings

Signature - Title
John E. Bateman - Chief Operating Officer
Location
Dallas, TX
Options holdings as of
June 30, 2019
Notional value $
$423M
Number of holdings
2
Date filed
8/14/2019, 01:09 PM
Description
A portion of the US holdings for this investor are reported in this report and a portion are reported by other reporting manager(s).
Previous filing
Q1 2019 - May 15, 2019
Stock holdings
Showing options holdings, see here for stock holdings
Sym Company Class Option Share Change Activity * Price $ Shares Notional Value
Filing 2019 Q2 compared to 2019 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
John E. Bateman Chief Operating Officer Dallas, Texas 8/14/2019

This Form 13F includes only the reportable 3,023,349 Class A shares of Reata Pharmaceuticals, Inc. ("Reata") over which CPMG, Inc. ("CPMG") had investment discretion as of June 30, 2019. This Form 13F does not include the 1,692,857 Class B shares of Reata over which CPMG had investment discretion as of June 30, 2019 because such Class B shares were not included in the relevant quarter's Official List of Section 13(f) Securities, and thus should be excluded.